Treace Medical Concepts, Inc.: revenue
Revenue for Treace Medical Concepts, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Treace Medical Concepts, Inc. financial histories
What this measure means
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
Exact concept: us-gaap:Revenues. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 212,690,000 | USD | 2026-02-27 | 10-K · 0001193125-26-079167 |
| 2024-01-01 | 2024-12-31 | 209,357,000 | USD | 2026-02-27 | 10-K · 0001193125-26-079167 |
| 2023-01-01 | 2023-12-31 | 187,118,000 | USD | 2026-02-27 | 10-K · 0001193125-26-079167 |
| 2022-01-01 | 2022-12-31 | 141,838,000 | USD | 2025-02-27 | 10-K · 0000950170-25-029029 |
| 2021-01-01 | 2021-12-31 | 94,419,000 | USD | 2024-02-27 | 10-K · 0000950170-24-021228 |
| 2020-01-01 | 2020-12-31 | 57,365,000 | USD | 2023-03-08 | 10-K · 0000950170-23-006603 |
| 2019-01-01 | 2019-12-31 | 39,416,000 | USD | 2022-03-04 | 10-K · 0000950170-22-002903 |
Related financial histories
- Treace Medical Concepts, Inc.: total assets
- Treace Medical Concepts, Inc.: total liabilities
- Treace Medical Concepts, Inc.: stockholders equity
- Treace Medical Concepts, Inc.: cash and cash equivalents
- Treace Medical Concepts, Inc.: net income or loss
- Treace Medical Concepts, Inc.: operating cash flow
- Treace Medical Concepts, Inc.: capital expenditure payments
- Treace Medical Concepts, Inc.: financing cash flow
- Treace Medical Concepts, Inc.: investing cash flow
- Treace Medical Concepts, Inc.: retained earnings or deficit
- Treace Medical Concepts, Inc.: basic weighted-average shares
- Treace Medical Concepts, Inc.: diluted weighted-average shares
- Treace Medical Concepts, Inc.: basic earnings per share
- Treace Medical Concepts, Inc.: diluted earnings per share
- Treace Medical Concepts, Inc.: net property, plant and equipment
- Treace Medical Concepts, Inc.: share-based compensation expense
- Treace Medical Concepts, Inc.: operating income or loss
- Treace Medical Concepts, Inc.: current assets
- Treace Medical Concepts, Inc.: interest expense
- Treace Medical Concepts, Inc.: current liabilities
- Treace Medical Concepts, Inc.: current accounts payable
- Treace Medical Concepts, Inc.: goodwill carrying amount
- Treace Medical Concepts, Inc.: net current accounts receivable
- Treace Medical Concepts, Inc.: operating expenses
- Treace Medical Concepts, Inc.: net inventory
- Treace Medical Concepts, Inc.: gross profit
- Treace Medical Concepts, Inc.: research and development expense
Inspect the source
- Entity
- Treace Medical Concepts, Inc. / CIK 0001630627
- Captured
- 2026-09-21T17:22:17.671Z
- SEC response SHA-256
dd86a0c760297ca046815f50e7c07f23133dc4921945dd85891fa59732976b74
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001630627.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))